Logo of Huzzle

Intern, Clinical Pharmacology

Applications are closed

  • Internship
    Full-time
    Summer Internship
  • Science

Requirements

  • Required Skills:
  • Strong training in PK/PD analyses with a preference for population-based modeling and simulation
  • Extensive hands-on experience with non-compartmental and compartmental PK/PD analysis software
  • Excellent written and verbal communication skills
  • Desired Skills:
  • Experience in clinical/nonclinical PK/PD study design, implementation, and interpretation
  • Ability to work in a matrix environment and with different leadership styles
  • Qualifications/Eligibility:
  • PhD student with a strong interest in Clinical Pharmacology, Pharmacokinetics, PK/PD Modeling and Simulation
  • Student must be returning to school in the Fall Term OR has graduated within the 1 year of the start of the program
  • Must be available to work 40 hours a week
  • Must be authorized to work in the United States without visa sponsorship

Responsibilities

  • The BioMarin Summer Internship Program will enable students to gain valuable experience and knowledge of the processes and systems within BioMarin, while gaining an insight into the pharmaceutical/biotech industry.
  • The Clinical Pharmacology group is responsible for the design, execution, interpretation, and reporting of nonclinical and clinical pharmacology aspects of BioMarin’s development and commercial pipeline. This includes the assessment of PK/PD relationships of small molecule, biologic and gene therapy drug candidates that are situated throughout all stages of development (Phase 0-IV). Team members are responsible for the planning, implementation, and organization of regulatory filings along with presentation of clinical pharmacology data to internal cross-functional teams, external collaborators, US and ex-US regulatory authorities and the scientific community.

We transform lives through genetic discovery.

Science & Healthcare
Industry
1001-5000
Employees
1997
Founded Year

Mission & Purpose

Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact.